FELTON, California,
October 23, 2017 /PRNewswire/ --
The global coagulation analyzers & reagents market
size was worth USD 3.3 billion in
2015 and is likely to grow at a CAGR of over 10.2% over the
forecast period. The growth of this market is supported by
increasing number of lifestyle disorders and chronic blood related
disorders.
The increase in the volume of testing can be attributed to the
augmented awareness among people towards lifestyle and blood
disorders which is expected to further improve the diagnostic rate
and preventive care management. The study covers developing
countries which are undergoing paradigm shift and are highly
investing government funds for the procurement and installation of
these medical devices in the public healthcare facilities.
Analyzers are one of the most critical and important equipment
used for diagnosis, currently owing to multiple factors and thus
are expected to have a lucrative CAGR in the forecasted period. The
major factors driving the growth of this segment are increasing
incidences of the lifestyle disorders such as diabetes,
cardiovascular disorders and obesity combined with developing
healthcare infrastructure and spending on healthcare.
The factor expected to propel the growth of the diagnostics
market, are providing timely and quality care to the patients which
in turn is expected to hike the demand for hemostasis analyzers.
The class of hemostasis analyzers recording the majority of the
shares in 2015 is the clinical laboratory analyzers which are
predominantly used in the hospitals for the hematological analysis
of the patients on a daily basis.
Browse 120 page research report
with TOC on "Global Coagulation Analyzers
& Reagents Market" at:
https://www.millioninsights.com/industry-reports/coagulation-analyzers-reagents-market
Over the period of forecast, optical technology is estimated to
hold majority of the shares due to the increasing combination of
photo optical method with immunologics and chromogenics. This
combination has led to the development of multipurpose, high
performance optical hemostasis analyzers.
In the context of test types, maximum shares were recorded to be
held by the prothrombin segment followed by the APTT test segment
in 2015. High popularity among the physicians for the
aforementioned tests is responsible for the large shares.
The major drivers for the end-use segment of the coagulation
analyzer market are rapid expansion in primary healthcare centers
and hospitals, favorable government regulations in the healthcare
facilities combined with availability of advanced equipment with
capacity to perform high accuracy multiple tests.
North America held majority of
the revenue shares in 2015 for the global market, which is around
35.0%. The major drivers for this region are increasing prevalence
of disorders belonging to the cardio metabolic class like Pulmonary
Embolism (PE), and Deep Vein Thrombosis (DVT) and presence of
well-established healthcare services.
Major players in the market are namely Siemens Healthcare,
Instrumentation Laboratory, and Roche Diagnostics, Alere, Inc.,
Thermo Fischer Scientific, and Nihon Kohden. Due to the easy global
accessibility in this market, the major players are already present
in across various countries and are competing to secure the higher
market share.
Browse reports of similar category available
with Million Insights:
- Cervical Dysplasia Market -
https://www.millioninsights.com/industry-reports/cervical-dysplasia-market
- Baby Eczema Cream Market -
https://www.millioninsights.com/industry-reports/baby-eczema-cream-market
- Travel Vaccines Market -
https://www.millioninsights.com/industry-reports/travel-vaccines-market
- AIDS Rapid Test Kit Market -
https://www.millioninsights.com/industry-reports/aids-rapid-test-kit-market
Market Segmentation:
Product Outlook (Revenue, USD Million, 2013 -
2024)
• Analyzers
•
Clinical Laboratory Analyzers
• Point
of Care Analyzers
• Consumables
•
Reagents
•
Stains
Technology Outlook (Revenue, USD Million, 2013 -
2024)
• Mechanical
• Electrochemical
• Optical
• Photo
optical/Chromogenic/Immuno
•
Others/Nephelometric
• Others
Test Type Outlook (Revenue, USD Million, 2013 -
2024)
• APTT
• D-Dimer
• Fibrinogen
• Prothrombin
• Others
End-Use Outlook (Revenue, USD Million, 2013 -
2024)
• Hospitals
• Research Institutes
• Diagnostic Centers
• Others
Regional Outlook (Revenue, USD Million, 2013 -
2024)
• North
America
•
U.S.
•
Canada
• Europe
• UK
•
Germany
• Asia
Pacific
•
Japan
•
China
• Latin
America
•
Brazil
•
Mexico
• MEA
•
South Africa
About Million Insights:
Million Insights, is a distributor of market research reports,
published by premium publishers only. We have a comprehensive
market place, that will enable you to compare data points, before
you make a purchase. Enabling informed buying, is our motto and we
strive hard to ensure that our clients get to browse through
multiple samples, prior to an investment. Service flexibility &
the fastest response time are two pillars, on which our business
model is founded. Our market research report store, includes
in-depth reports, from across various industry verticals, such as
healthcare, technology, chemicals, food & beverages, consumer
goods, material science & automotive.
Contact:
Ryan Manuel
Research Support Specialist, USA
Million Insights
Phone: +1-408-610-2300
Toll Free: 1-866-831-4085
Email: sales@millioninsights.com
Web: https://www.millioninsights.com/